GlassScriptPhysician profile
James H Law
NPI 1861460370
$3,193.95
in general payments reported to CMS, 2019-2025
36 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $627 · 2021: $637 · 2022: $292 · 2023: $708 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $647.75 | 2019-2023 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $466.11 | 2019-2023 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Genentech USA, INC. | $244.58 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $196.69 | 2019-2025 | Tezspire, Breztri |
| Novo Nordisk INC | $180.00 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $161.47 | 2019-2020 | |
| Abbvie INC. | $114.78 | 2020-2023 | |
| Lilly USA, LLC | $111.38 | 2020-2023 | Trulicity, Mounjaro, Jardiance |
| Pfizer INC. | $101.96 | 2019-2023 | |
| Abbott Laboratories | $95.57 | 2020 | |
| Vanda Pharmaceuticals INC. | $93.16 | 2020 | |
| Allergan, INC. | $88.79 | 2019-2020 | |
| Genzyme Corporation | $87.09 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $83.38 | 2019-2023 | Keytruda |
| Baxter Healthcare | $76.96 | 2023 | Hillrom - Life 2000 Ventilation System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $50.29 | 2021-2023 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $34.61 | 2023 | Glassia |
| Regeneron Healthcare Solutions, INC. | $34.47 | 2021 | |
| Grifols USA, LLC | $32.92 | 2020-2023 | Prolastin-C Liquid |
| Medtronic, INC. | $23.65 | 2022 | |
| Axsome Therapeutics, INC. | $21.00 | 2023 | Sunosi |
| Hologic Sales and Service, LLC | $20.64 | 2022 | |
| Exeltis, USA INC. | $20.60 | 2023 | Slynd |
| Actelion Pharmaceuticals US, INC. | $19.32 | 2021 | |
| Mayne Pharma Commercial LLC | $18.77 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.84 | 2019 | |
| Amgen INC. | $17.67 | 2022 | |
| Insmed, INC. | $16.61 | 2021 | |
| Philips North America LLC | $16.39 | 2020 | |
| Vivus LLC | $15.96 | 2019 | |
| Edwards Lifesciences Corporation | $15.79 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Csl Behring | $14.64 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.43 | 2021 | |
| Vertiflex, INC. | $14.00 | 2019 | |
| Tactile Systems Technology INC | $12.38 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.